FindTrial
Sign In

Mutation in breast cancer

Estimation of TP53 gene mutation from Circulating DNA of Breast cancer tumor. - Estimate TP53 mutation in Ca breast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036282
Enrollment
271
Registered
2021-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Drashti Rao Self sponsor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with pre-existing breast cancer A patient who has complete clinicopathological data. A patient who will have sufficient blood samples for DNA analysis.

Exclusion criteria

Exclusion criteria: There is no exclusion criteria for this study

Design outcomes

Primary

MeasureTime frame
To evaluate rate of TP53 gene mutation in breast cancer patient of Sir T Hospital, Bhavnagar Timepoint: 2 years—

Secondary

MeasureTime frame
1.To assess the association with family history, menopause, age and environmental factor. 2.To correlate with other blood investigation (CBC) and BMI Timepoint: 2 years—

Countries

India

Contacts

Public ContactDrashti Ajitbhai Rao

and Govt. Medical College Bhavnagar

hariom_sharma2000@yahoo.com9723461414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026